VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH CANCER CORPUS UTERI

2017 ◽  
Author(s):  
Henriette Strøm Kahr
Keyword(s):  
Thromboembolic Complications ◽  
Patients With Cancer ◽  
Corpus Uteri ◽  
Venous Thromboembolic

Venous Thromboembolic Complications in Patients with Cancer Corpus Uteri

2018 ◽  
Vol 164 ◽  
pp. S217
Author(s):  
H. Strøm Kahr ◽  
O. Thorlacius-Ussing ◽  
O.B. Christiansen ◽  
A. Grove ◽  
C. Torp-Pedersen ◽  
...  
Keyword(s):  
Thromboembolic Complications ◽  
Patients With Cancer ◽  
Corpus Uteri ◽  
Venous Thromboembolic

Venous thromboembolic complications in patients with intracerebral hemorrhage

2021 ◽  
Vol 121 (8) ◽  
pp. 41
Author(s):  
A.I. Khripun ◽  
A.D. Pryamikov ◽  
A.B. Mironkov ◽  
S.A. Asratyan ◽  
V.S. Suryakhin ◽  
...  
Keyword(s):  
Intracerebral Hemorrhage ◽  
Thromboembolic Complications ◽  
Venous Thromboembolic

Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors

2018 ◽  
Vol 34 (5) ◽  
pp. 870-879 ◽  
Author(s):  
Yuki Ohta ◽  
Makoto Arai ◽  
Tomoo Nakagawa ◽  
Naoki Akizue ◽  
Kentaro Ishikawa ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Thromboembolic Complications ◽  
Venous Thromboembolic ◽  
Inflammatory Bowel

Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review

Amyloid ◽  
2012 ◽  
Vol 19 (3) ◽  
pp. 156-160 ◽  
Author(s):  
Benjamin Freeman ◽  
J. Mark Sloan ◽  
David C. Seldin ◽  
Andrew J. Cowan ◽  
Frederick L. Ruberg ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Cardiac Involvement ◽  
Al Amyloidosis ◽  
Thromboembolic Complications ◽  
Venous Thromboembolic

scholarly journals Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients

2018 ◽  
pp. 106-112
Author(s):  
N. V. Vorobyev ◽  
S. V. Popov
Keyword(s):  
Molecular Weight ◽  
Impaired Renal Function ◽  
Low Molecular Weight Heparin ◽  
Low Molecular Weight ◽  
Efficacy And Safety ◽  
Thromboembolic Complications ◽  
Antithrombotic Effect ◽  
Low Molecular Weight Heparins ◽  
Prevention And Treatment ◽  
Venous Thromboembolic

Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect. The article presents a review of the clinical studies of efficacy and safety, and the experience in using of modern low-molecular-weight heparins in clinical practice - drugs of choice for the prevention of venous thromboembolic complications in cancer patients. Particular attention is paid to Bemiparin - a new second-generation low-molecular-weight heparin with a significant antithrombotic effect and improved pharmacological parameters that allow it to be successfully used in patients with impaired renal function in oncourological practice.

Sign in / Sign up

Export Citation Format

Share Document